BVF II GP, Director: MoonLake Immunotherapeutics MLTX Sell · Filed 24/10/08

Trade details

Type: Insider sale
Amount: $51,529,450
Shares · price: 1,030,589 sh · $50.00 a share
Held after: 10,235,089 sh
Stock: MoonLake Immunotherapeutics MLTX
Person: BVF II GPDirector
Trade date: 24/10/04
Filed: 24/10/08
Days to filing: 4 days

Sold 9.1% of holdings

Share of holding sold: 9.1%

MoonLake Immunotherapeutics trades, last 26 weeks

What else happened in MoonLake Immunotherapeutics around then

Filed or reported within 30 days of the trade day · 24/09/04~24/11/03

BVF II GP's recent trades

BVF II GPDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
BVF II GPDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
BVF II GPDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
BVF II GPDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
BVF II GPDirector
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$32.4M
1,932,354 sh
$32.4M
Filed 04/02
Traded 03/31

BVF II GP, Director — sold $51.5M of MoonLake Immunotherapeutics MLTX · 9.1% of holdings | Whalegun